Dolby Laboratories, Inc.
Close on Oct 19, 2026
- Market cap
- $5.77B
- P/E (TTM)
- 26.0
- Dividend yield
- 2.16%
Earnings
Next report expected Nov 17, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2026 Ended Jun 26, 2026 | Jul 30, 2026 | After market close | $305.00M | $0.30 | $0.69 |
| Q2 FY2026 Ended Mar 27, 2026 | Apr 30, 2026 | After market close | $396.00M | $0.99 | $1.37 |
| Q1 FY2026 Ended Dec 26, 2025 | Jan 29, 2026 | After market close | $347.00M | $0.55 | $1.06 |
| Q4 FY2025 Ended Sep 26, 2025 | Nov 18, 2025 | After market close | $307.00M | $0.51 | $0.99 |
| Q3 FY2025 Ended Jun 27, 2025 | Jul 31, 2025 | After market close | $316.00M | $0.48 | $0.78 |
| Q2 FY2025 Ended Mar 28, 2025 | May 1, 2025 | After market close | $370.00M | $0.94 | $1.34 |
| Q1 FY2025 Ended Dec 27, 2024 | Jan 29, 2025 | After market close | $357.00M | $0.70 | $1.14 |
| Q4 FY2024 Ended Sep 27, 2024 | Nov 19, 2024 | After market close | $305.00M | $0.61 | $0.81 |
| Q3 FY2024 Ended Jun 28, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q2 FY2024 Ended Mar 29, 2024 | May 2, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Dec 29, 2023 | Feb 1, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Jul 30, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Diluted earnings per sharenon-GAAP | full year of fiscal 2026 | $4.25 to $4.40 | Lowered |
| Diluted earnings per sharenon-GAAP | fourth quarter of fiscal 2026 | $1.13 to $1.28 | New |
| Diluted earnings per shareGAAP | full year of fiscal 2026 | $2.62 to $2.77 | Lowered |
| Diluted earnings per shareGAAP | fourth quarter of fiscal 2026 | $0.78 to $0.93 | New |
| Gross marginsGAAP | full year of fiscal 2026 | 88% | Maintained |
| Gross marginsnon-GAAP | full year of fiscal 2026 | 90% | Maintained |
| Gross marginsGAAP | fourth quarter of fiscal 2026 | 88% | New |
| Gross marginsnon-GAAP | fourth quarter of fiscal 2026 | 90% | New |
| operating marginsGAAP | full year of fiscal 2026 | 21% | Maintained |
| operating marginsnon-GAAP | full year of fiscal 2026 | 34% | Maintained |
| Effective tax rateGAAP | full year of fiscal 2026 | 24% | Raised |
| Effective tax ratenon-GAAP | full year of fiscal 2026 | 21% | Raised |
| Licensing revenue | full year of fiscal 2026 | $1.31B to $1.34B | Narrowed |
| Operating expensesGAAP | full year of fiscal 2026 | $937.00M to $947.00M | Narrowed |
| Operating expensesnon-GAAP | full year of fiscal 2026 | $785.00M to $795.00M | Narrowed |
| Effective tax rateGAAP | fourth quarter of fiscal 2026 | 23% | New |
| Effective tax ratenon-GAAP | fourth quarter of fiscal 2026 | 21% | New |
| Licensing revenue | fourth quarter of fiscal 2026 | $335.00M to $365.00M | New |
| Operating expensesGAAP | fourth quarter of fiscal 2026 | $227.00M to $237.00M | New |
| Operating expensesnon-GAAP | fourth quarter of fiscal 2026 | $195.00M to $205.00M | New |
| Total revenue | full year of fiscal 2026 | $1.41B to $1.44B | Narrowed |
| Total revenue | fourth quarter of fiscal 2026 | $362.00M to $392.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Dolby Laboratories filed with the SEC
Dolby Laboratories Announces Leadership Transition
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Third Quarter 2026 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Second Quarter 2026 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports First Quarter 2026 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Third Quarter 2025 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Second Quarter 2025 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports First Quarter 2025 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Material agreement · Results of operations · New financial obligation · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Third Quarter 2024 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Announces Agreement to Acquire GE Licensing from GE Aerospace
Regulation FD disclosure · EX-99.1 to Form 8-K
Dolby Laboratories Reports Second Quarter 2024 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports First Quarter 2024 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Results of operations · Executive or director change · Other events · EX-99.1 to Form 8-K
2024 DOLBY EXECUTIVE BONUS PLAN
Results of operations · Executive or director change · Other events · EX-99.2 to Form 8-K
Dolby Laboratories Reports Third Quarter Fiscal 2023 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Second Quarter Fiscal 2023 Financial
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports First Quarter 2023 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial
Results of operations · Other events · EX-99.1 to Form 8-K
Dolby Laboratories Reports Third Quarter Fiscal 2022 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K